Medicine and Health

Galactooligosaccharides and *Limosilactobacillus reuteri* synergistically alleviate gut inflammation and barrier dysfunction by enriching *Bacteroides acidifaciens* for pentadecanoic acid biosynthesis

Y. Wu, X. Zhang, et al.

This groundbreaking study reveals the remarkable therapeutic effects of a synbiotic formulation of galactooligosaccharides and *Limosilactobacillus reuteri* in combating colitis. Researchers discovered that this synbiotic not only enhances gut health by boosting levels of *Bacteroides acidifaciens*, but also supports inflammation reduction through pentadecanoic acid synthesis. Conducted by Yujun Wu and colleagues, this research opens new avenues for treating inflammatory bowel disorders.